Trending Topic

A digital rendering of a human brain with highlighted neural pathways and electric activity, visualizing brain function.
18 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
Pavel Burko, Ilias Miltiadis, Mahsa Alavi

Amyotrophic lateral sclerosis (ALS) is characterized by the degeneration of both upper and lower motor neurons, which ultimately leads to muscle weakness, atrophy, spasticity and contractures.1 ALS typically manifests in the 50–60 years age range, although familial cases may present in late adolescence or early adulthood.2 The time from the first symptom to diagnosis is approximately 10–16 […]

Why Are Children and Adolescents with 22q11.2 Deletion Syndrome at High Risk of Developing Schizophrenia?

Stephan Eliez, Martin Debbané
Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Jun 4th 2011
Select a Section…
1

Abstract

Overview

Because almost one-third of individuals affected by 22q11.2 deletion syndrome (22q11DS) develop schizophreniform disorders,1 the field of psychiatry and cognitive psychopathology has become increasingly interested in uncovering the mechanisms leading to psychosis in this population. Many view this deletion syndrome as a model for understanding the development of schizophrenia. The relevance of 22q11DS to the field of schizophrenia research was first established by demonstrating that the psychotic-like manifestation in this deletion syndrome represented frank psychotic manifestations as opposed to residual symptoms originating from mental retardation.2,3

2

Article

These initial efforts were followed by a larger study involving 50 adults affected with 22q11DS.1 The complete psychiatric evaluations performed with this sample revealed that 15 participants (30%) met the diagnostic criteria for a psychotic disorder, with 12 (24%) meeting the schizophrenia criteria. Employing a different investigational strategy, Karayiorgou et al. randomly assessed for 22q11DS in 100 individuals with schizophrenia, and found that two individuals never before screened for the deletion actually tested positive for 22q11DS.4 In another study, medical records were initially screened for patients with the cardinal features of 22q11DS (cardiac anomalies and cleft palate), and then cross-referenced with records from the psychiatric hospitals.5 When screening for 22q11DS in these potential cases, the authors found that 14% of the patient sample with schizophrenia was also affected with 22q11DS. Finally, in a large group of children with childhood-onset schizophrenia (COS), four participants out of 75 (5.3%) were found to also have 22q11DS.6 The observations collected to date establish solid evidence to the effect that schizophrenia affects individuals with 22q11DS. They further suggest that, with the exception of having a monozygotic twin with schizophrenia or wo parents with schizophrenia, 22q11DS represents the strongest genetic risk factor associated with psychotic disorders.7

As is often thecase in psychiatry, we confer ‘psychiatric risk’ status to children and adolescents exhibiting the cardinal features of adult psychiatric disorders. Today, fields of investigation such as those concerning paediatric bipolar disorder or high-risk adolescents in the schizophrenia prodrome are gaining significant momentum based on the assessment of subclinical symptom expressions using adult diagnostic criteria. Interestingly, the field of 22q11DS research has developed in a similar fashion. By identifying the clinical importance of schizophrenia in this deletion syndrome, we naturally assume that children and adolescents with the deletion run a very high risk of developing schizophrenia.

To view full article click here

3

Further Resources

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup